Listen to your body's signals rather than forcing yourself to eat on a schedule
A healthcare provider will determine the appropriate "wash-out" period and the correct starting dosing for the new medication to ensure a safe and effective transition in administration
Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes (SURPASS-2): a randomised, open-label, parallel-group, multicentre, phase 3 trial
Registration as a 503B outsourcing facility is optional, so traditional 503A compounding pharmacies, which provide individual patients with customized medications on a prescription-basis, are not required to register as a 503B facility
Waistlines shrink, faces slim down, energy improves, but the transformation remains subtle enough that distant acquaintances might not comment yet